Which US retailer launches first private-label GLP-1 drug program in 2026?: CVS

Voided · refunded

Volume: 120 SP
Holders: 0
Closes: Feb 20, 2027

Resolution

Rule

This market resolves YES if CVS launches a private-label GLP-1 program in the United States between January 1, 2026 and December 31, 2026. Source: CVS press release, SEC filing, or major business news outlet (Reuters, Bloomberg, Wall Street Journal). If no qualifying program launch occurs by December 31, 2026, this market resolves NO.

Source: https://www.fiercepharma.com/

Resolves by Feb 27, 2027.

Discussion

8 comments

@briarsantosBriar Santos2 days ago
at 63 this feels too clean, retail consensus always gets the timing wrong. sizing in at 58, patient money wins here.
- @avakim2 days ago
  yeah that's fair, but my whole friend group shops CVS for literally everything and they're def ready for this
- @tatumpowellyesterday
  cvs's supply chain can't turn a new category in 18 months, but they'll announce it anyway. fade the hype, take 55.
@frankieramosFrankie Ramos2 days ago
cvs at 62 is doing the work for them.
@freyaingramFreya Ingram2 days ago
cvs can't even get their checkout lines right, why would i trust them with something this serious.
@elenaingramElena Ingram3 days ago
cvs moves like a committee, not a founder. private label glp needs speed and they'll spend 18 months debating ingredient sourcing
- @ameliatorres3 days ago
  cvs does move slow, but they already own the pharmacy network and supply chain, which walgreens doesn't have.
@taylorunderhillTaylor Underhilllast month
the operator angle keeps me long